Published: 1 August 2018
Author(s): Aude Lecadet, Claude Bachmeyer, David Buob, Alexandre Cez, Sophie Georgin-Lavialle
Issue: August 2018
Section: Letter to the Editor

The term “amyloidosis” encompasses a large group of diseases characterized by extracellular deposition of fibrillar proteins impairing organ function. Classification of amyloidosis relies on the nature of the protein and the deposition site. Systemic amyloidosis includes mainly immunoglobulin light chains (AL) amyloidosis, transthyretin (TTR) amyloidosis, either wild-type or hereditary, and “reactive” amyloid A (AA) amyloidosis [1, 2].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.